Best in Biotech 18 Mar 2025
Cancer vaccines: 11 biotechs to keep an eye out for
As various biotechs across the world specialize in the production of cancer vaccines, here are 11 companies making progress in the field.
Vaccines
- Latest Posts
In Depth 12 Feb 2025
Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates
Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic.
In Depth 5 Feb 2025
Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space.
In Depth 17 Dec 2024
Ovarian cancer: BioNTech, Curelab, OvarianVax and more bring vaccines to the clinic
A number of ovarian cancer vaccines are being evaluated including the world’s first cancer prevention vaccine, which recently received funding.
In Depth 2 Dec 2024
The rise of cancer vaccines: A new era in immunotherapy
Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.
News and Trends 29 Nov 2024
Trump’s healthcare picks: Who they are and what they mean for the biopharma industry
Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?
ADVERTISEMENT
ADVERTISEMENT
In Depth 6 Nov 2024
Tuberculosis research: Are we finally close to developing a more effective treatment option?
Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options.
News and Trends 30 Sep 2024
The race for a bird flu vaccine: milestones and breakthroughs
The recent uptick in U.S. bird flu cases poses a threat to public health. Biotechs are now developing vaccines to mitigate the outbreak.
News and Trends 23 Sep 2024
Vicebio and its molecular clamp vaccine raise big to tackle respiratory viruses
Discover Vicebio’s molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against RSV and hMPV.
Podcast 30 Aug 2024
The future of combination vaccines
To look at combination vaccines, listen to our conversation with Cesar Sanz Rodriguez, vice president, Europe & Switzerland, medical affairs, at Moderna.
In Depth 9 Aug 2024
The therapeutic potential of circular RNA: Could it soon trump mRNA technology?
Find out about circular RNA, an emerging technology that could hold a lot of promise for next-generation vaccines and gene therapies.
News and Trends 29 Jul 2024
Influenza solution deals pile up as pandemic preparedness increases
Influenza deals have been piling up in the last few weeks. Discover why that is and how are companies and government preparing for pandemics.
ADVERTISEMENT
